{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:33:27Z","timestamp":1765546407738,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To explore the influence of dermatomyositis (DM)-specific cutaneous manifestations (scm) on systemic coagulation and fibrinolysis, we retrospectively studied plasma D-dimer levels with\/without venous thromboembolism (VTE), malignancy, infection or other connective tissue diseases (CTDs) and scm. One hundred fifty patients with DM were retrospectively investigated using medical records regarding scm, VTE, malignancy, infection, other CTDs, laboratory data and systemic corticosteroid therapy. All DM patients were categorized as follows: group 1, without scm, VTE, infection, malignancy or other accompanying CTDs; group 2, with scm only; and group 3, with VTE, infection, malignancy and other accompanying CTDs but without scm. The D-dimer plasma levels were significantly increased in group 3 compared with healthy subjects and those in groups 1 and 2 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The D-dimer plasma level in group 2 was significantly increased compared with healthy subjects and those in group 1 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Increased D-dimer plasma levels were detected in DM patients with scm without detectable VTE, malignancy, infection or accompanying CTDs. In addition to the known risk factors for increased plasma D-dimer levels in DM patients, including VTE, malignancy, infection and other accompanying autoimmune diseases, the presence of cutaneous manifestations should be considered as a new clinical risk factor.<\/jats:p>","DOI":"10.1038\/s41598-018-38108-y","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T11:04:11Z","timestamp":1549364651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations"],"prefix":"10.1038","volume":"9","author":[{"given":"Koji","family":"Habe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Akeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenshiro","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kakeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3055-5202","authenticated-orcid":false,"given":"Keiichi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"issue":"9162","key":"38108_CR1","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","volume":"353","author":"SZ Goldhaber","year":"1999","unstructured":"Goldhaber, S. Z., Visani, L. & De Rosa, M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 353(9162), 1386\u20139 (1999).","journal-title":"Lancet."},{"issue":"11","key":"38108_CR2","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3899\/jrheum.080478","volume":"35","author":"SD Gaitonde","year":"2008","unstructured":"Gaitonde, S. D. & Ballou, S. P. Deep venous thrombosis in dermatomyositis. J Rheumatol. 35(11), 2288 (2008).","journal-title":"J Rheumatol."},{"issue":"9812","key":"38108_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","volume":"379","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller, B., Li, X., Sundquist, J. & Sundquist, K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 379(9812), 244\u2013249 (2012).","journal-title":"Lancet."},{"issue":"3","key":"38108_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.thromres.2014.06.021","volume":"134","author":"WS Chung","year":"2014","unstructured":"Chung, W. S., Lin, C. L., Sung, F. C., Lu, C. C. & Kao, C. H. Increased risk of venous thromboembolism in patients with dermatomyositis\/polymyositis: a nationwide cohort study. Thromb Res. 134(3), 622\u2013626 (2014).","journal-title":"Thromb Res."},{"key":"38108_CR5","volume":"10","author":"SV Ramagopalan","year":"2011","unstructured":"Ramagopalan, S. V., Wotton, C. J., Handel, A. E., Yeates, D. & Goldacre, M. J. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 10, 9:1 (2011).","journal-title":"BMC Med."},{"issue":"5","key":"38108_CR6","first-page":"846","volume":"29","author":"A Selva-O\u2019Callaghan","year":"2011","unstructured":"Selva-O\u2019Callaghan, A., Fern\u00e1ndez-Luque, A., Mart\u00ednez-G\u00f3mez, X., Labirua-Iturburu, A. & Vilardell-Tarr\u00e9s, M. Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol. 29(5), 846\u20139 (2011).","journal-title":"Clin Exp Rheumatol."},{"key":"38108_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/annrheumdis-2014-205800","volume":"75","author":"EC Carruthers","year":"2016","unstructured":"Carruthers, E. C., Choi, H. K., Sayre, E. C. & Avi\u00f1a-Zubieta, J. A. Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study. Ann Rheum Dis. 75, 110\u2013116 (2016).","journal-title":"Ann Rheum Dis."},{"key":"38108_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.bjc.6603989","volume":"97","author":"T Satoh","year":"2007","unstructured":"Satoh, T. et al. High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer. 97, 1053\u20131057 (2007).","journal-title":"Br J Cancer."},{"key":"38108_CR9","first-page":"I22","volume":"107","author":"C Kearon","year":"2003","unstructured":"Kearon, C. Natural history of venous thromboembolism. Circulation. 107, I22\u201330 (2003).","journal-title":"Circulation."},{"issue":"2","key":"38108_CR10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","volume":"82","author":"J Cermak","year":"1993","unstructured":"Cermak, J. et al. Vercellotti. C-Reactive Protein Induces Human Peripheral Blood Monocytes to Synthesize Tissue Factor. Blood. 82(2), 513\u2013520 (1993).","journal-title":"Blood."},{"issue":"2 Suppl","key":"38108_CR11","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","volume":"38","author":"M Levi","year":"2010","unstructured":"Levi, M. & van der Poll, T. Inflammation and coagulation. Crit Care Med. 38(2 Suppl), S26\u201334 (2010).","journal-title":"Crit Care Med."},{"key":"38108_CR12","doi-asserted-by":"crossref","unstructured":"Yamanaka, K. et al. Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: the potential of anti-IL-1 therapy for systemic inflammatory diseases. PLoS One Aug 13; 9(8) (2014).","DOI":"10.1371\/journal.pone.0104479"},{"key":"38108_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 292, 403\u20137 (1975).","journal-title":"N Engl J Med."},{"key":"38108_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N Engle J Med. 292, 344\u20137 (1975).","journal-title":"N Engle J Med."},{"issue":"6","key":"38108_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00002281-199911000-00005","volume":"11","author":"RD Sontheimer","year":"1999","unstructured":"Sontheimer, R. D. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol. 11(6), 475\u2013482 (1999).","journal-title":"Curr Opin Rheumatol."},{"issue":"4","key":"38108_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer, R. D. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 46(4), 626\u2013636 (2002).","journal-title":"J Am Acad Dermatol."},{"key":"38108_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-015-8496-5","volume":"51","author":"Y Muro","year":"2016","unstructured":"Muro, Y., Sugiura, K. & Akiyama, M. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review. Clinic Rev Allerg Immunol. 51, 293\u2013302 (2016).","journal-title":"Clinic Rev Allerg Immunol."},{"issue":"6","key":"38108_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/archinte.158.6.585","volume":"158","author":"MD Silverstein","year":"1998","unstructured":"Silverstein, M. D. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 158(6), 585\u201393 (1998).","journal-title":"Arch Intern Med."},{"issue":"4","key":"38108_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.thromres.2006.12.015","volume":"120","author":"SQ Ben","year":"2007","unstructured":"Ben, S. Q. et al. The dynamic changes of LDH isoenzyme 3 and D-dimer following pulmonary thromboembolism in canine. Thromb Res. 120(4), 575\u201383 (2007).","journal-title":"Thromb Res."},{"issue":"2","key":"38108_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2310\/JIM.0000000000000041","volume":"62","author":"E Babaoglu","year":"2014","unstructured":"Babaoglu, E. et al. Importance of biomarkers in risk stratification of pulmonary thromboembolism patients. J Investig Med. 62(2), 328\u201331 (2014).","journal-title":"J Investig Med."},{"key":"38108_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.thromres.2005.06.006","volume":"118","author":"DJ Brotman","year":"2006","unstructured":"Brotman, D. J. et al. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res. 118, 247\u201352 (2006).","journal-title":"Thromb Res."},{"key":"38108_CR22","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1378\/chest.12-1446","volume":"143","author":"DJ Stuijver","year":"2013","unstructured":"Stuijver, D. J. et al. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case\u2013control study. Chest. 143, 1337\u201342 (2013).","journal-title":"Chest."},{"issue":"8 Pt 2","key":"38108_CR23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/clinchem\/44.8.1845","volume":"44","author":"J Fareed","year":"1998","unstructured":"Fareed, J. et al. Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Clin Chem. 44(8 Pt 2), 1845\u20131853 (1998).","journal-title":"Clin Chem."},{"issue":"6","key":"38108_CR24","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1538-7836.2006.01942.x","volume":"4","author":"H Wada","year":"2006","unstructured":"Wada, H. et al. Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis. J Thromb Haemost. 4(6), 1253\u20138 (2006).","journal-title":"J Thromb Haemost."},{"issue":"3","key":"38108_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1160\/TH14-07-0597","volume":"113","author":"M Mego","year":"2015","unstructured":"Mego, M. et al. Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer. Thromb Haemost. 113(3), 593\u20138 (2015).","journal-title":"Thromb Haemost."},{"issue":"2","key":"38108_CR26","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/cc2459","volume":"8","author":"GT Kinasewitz","year":"2004","unstructured":"Kinasewitz, G. T. et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care. 8(2), R82\u201390 (2004).","journal-title":"Crit Care."},{"issue":"2","key":"38108_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/art.1780390217","volume":"39","author":"M Inoh","year":"1996","unstructured":"Inoh, M., Tokuda, M., Kiuchi, H., Kurata, N. & Takahara, J. Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis. Arthritis Rheum. 39(2), 287\u201391 (1996).","journal-title":"Arthritis Rheum."},{"issue":"4","key":"38108_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon, C. T. The interactions between inflammation and coagulation. Br J Haematol. 131(4), 417\u201330 (2005).","journal-title":"Br J Haematol."},{"issue":"8","key":"38108_CR29","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamadermatol.2013.9944","volume":"150","author":"MG Kirchhof","year":"2014","unstructured":"Kirchhof, M. G., Lee, A. Y. & Dutz, J. P. D-dimer levels as a marker of cutaneous disease activity: case reports of cutaneous polyarteritis nodosa and atypical recurrent urticaria. JAMA Dermatol. 150(8), 880\u2013884 (2014).","journal-title":"JAMA Dermatol."},{"issue":"5","key":"38108_CR30","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1398-9995.2009.02222.x","volume":"65","author":"S Takahagi","year":"2010","unstructured":"Takahagi, S. et al. Coagulation\/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy. 65(5), 649\u2013656 (2010).","journal-title":"Allergy."},{"issue":"5","key":"38108_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/all.12587","volume":"70","author":"A Reshef","year":"2015","unstructured":"Reshef, A., Zanichelli, A., Longhurst, H., Relan, A. & Hack, C. E. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk. Allergy. 70(5), 506\u201313 (2015).","journal-title":"Allergy."},{"issue":"1","key":"38108_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2249.2012.04674.x","volume":"171","author":"AV Marzano","year":"2013","unstructured":"Marzano, A. V., Tedeschi, A., Polloni, I., Crosti, C. & Cugno, M. Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease. Clin Exp Immunol. 171(1), 76\u201381 (2013).","journal-title":"Clin Exp Immunol."},{"issue":"1","key":"38108_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2249.2011.04391.x","volume":"165","author":"AV Marzano","year":"2011","unstructured":"Marzano, A. V. et al. Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases. Clin Exp Immunol. 165(1), 44\u201350 (2011).","journal-title":"Clin Exp Immunol."},{"issue":"1","key":"38108_CR34","first-page":"85","volume":"10","author":"D Feldman","year":"1983","unstructured":"Feldman, D., Hochberg, M. C., Zizic, T. M. & Stevens, M. B. Cutaneous vasculitis in adult polymyositis\/dermatomyositis. J Rheumatol. 10(1), 85\u20139 (1983).","journal-title":"J Rheumatol."},{"issue":"4","key":"38108_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2230.2008.02729.x","volume":"33","author":"T Kawakami","year":"2008","unstructured":"Kawakami, T., Mizoguchi, M., Saito, R. & Soma, Y. Histopathological evidence of small-vessel vasculitis within the skin and lungs associated with interstitial pneumonia in an adult patient with dermatomyositis. Clin Exp Dermatol. 33(4), 415\u20137 (2008).","journal-title":"Clin Exp Dermatol."},{"issue":"1","key":"38108_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0046-8177(96)90132-X","volume":"27","author":"AN Crowson","year":"1996","unstructured":"Crowson, A. N. & Magro, C. M. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol. 27(1), 15\u20139 (1996).","journal-title":"Hum Pathol."},{"issue":"1","key":"38108_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"D Fiorentino","year":"2011","unstructured":"Fiorentino, D., Chung, L., Zwerner, J., Rosen, A. & Casciola-Rosen, L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 65(1), 25\u201334 (2011).","journal-title":"J Am Acad Dermatol."},{"key":"38108_CR38","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.V68.4.875.875","volume":"68","author":"T Wiedmer","year":"1986","unstructured":"Wiedmer, T., Esmon, C. T. & Sims, P. J. Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. Blood 68, 875\u2013880 (1986).","journal-title":"Blood"},{"issue":"9(5)","key":"38108_CR39","doi-asserted-by":"publisher","first-page":"e97843","DOI":"10.1371\/journal.pone.0097843","volume":"19","author":"TT Ma","year":"2014","unstructured":"Ma, T. T., Huang, Y. M., Wang, C., Zhao, M. H. & Chen, M. Coagulation and fibrinolysis index profile in patients with ANCA-associated vasculitis. PLoS One 19(9(5)), e97843 (2014).","journal-title":"PLoS One"},{"issue":"5","key":"38108_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1055\/s-0038-1650353","volume":"75","author":"H Akazawa","year":"1996","unstructured":"Akazawa, H., Ikeda, U., Yamamoto, K., Kuroda, T. & Shimada, K. Hypercoagulable state in patients with Takayasu\u2019s arteritis. Thromb Haemost. 75(5), 712\u20136 (1996).","journal-title":"Thromb Haemost."},{"issue":"7","key":"38108_CR41","first-page":"616","volume":"20","author":"AV Marzano","year":"2010","unstructured":"Marzano, A. V., Tedeschi, A., Rossio, R., Fanoni, D. & Cugno, M. Prothrombotic state in Churg-Strauss syndrome: a case report. J Investig Allergol Clin Immunol. 20(7), 616\u20139 (2010).","journal-title":"J Investig Allergol Clin Immunol."},{"issue":"12","key":"38108_CR42","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s004670100033","volume":"16","author":"K Brendel-M\u00fcller","year":"2001","unstructured":"Brendel-M\u00fcller, K., Hahn, A., Schneppenheim, R. & Santer, R. Laboratory signs of activated coagulation are common in Henoch-Sch\u00f6nlein purpura. Pediatr Nephrol. 16(12), 1084\u20138 (2001).","journal-title":"Pediatr Nephrol."},{"issue":"5","key":"38108_CR43","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/art.1780400514","volume":"40","author":"I Lundberg","year":"1997","unstructured":"Lundberg, I., Ulfgren, A. K., Nyberg, P., Andersson, U. & Klareskog, L. Cytokine production n muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40(5), 865\u201374 (1997).","journal-title":"Arthritis Rheum."},{"key":"38108_CR44","first-page":"904","volume":"33","author":"M Groh","year":"2015","unstructured":"Groh, M. et al. Interleukin-1 receptor antagonist for refractory anti-MDA5 clinically amyopathic dermatomyopathy. Clinical Experimental Rheumatology. 33, 904\u2013905 (2015).","journal-title":"Clinical Experimental Rheumatology."},{"issue":"7","key":"38108_CR45","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","volume":"15","author":"M Levi","year":"2005","unstructured":"Levi, M. & van der Poll, T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med. 15(7), 254\u20139 (2005).","journal-title":"Trends Cardiovasc Med."},{"issue":"4","key":"38108_CR46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1055\/s-0037-1613858","volume":"83","author":"BE van Aken","year":"2000","unstructured":"van Aken, B. E., den Heijer, M., Bos, G. M., van Deventer, S. J. & Reitsma, P. H. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost. 83(4), 536\u20139 (2000).","journal-title":"Thromb Haemost."},{"issue":"2","key":"38108_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ncpneph1021","volume":"5","author":"HJ Anders","year":"2009","unstructured":"Anders, H. J. Predicting thrombosis in systemic lupus erythmatosus. Nat Clin Pract Nephrol. 5(2), 68\u201369 (2009).","journal-title":"Nat Clin Pract Nephrol."},{"issue":"5","key":"38108_CR48","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jamadermatol.2014.5070","volume":"151","author":"MG Kirchhof","year":"2015","unstructured":"Kirchhof, M. G. & Dutz, J. P. Amyopathic dermatomyositis-related thrombophilia. JAMA Dermatol. 151(5), 559\u201361 (2015).","journal-title":"JAMA Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-38108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-38108-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-38108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:25:54Z","timestamp":1671254754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-38108-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["38108"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-38108-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"26 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1410"}}